SIMCERE PHARMAC. GRP LTD Working Capital to Net Assets Ratio
SIMCERE PHARMAC. GRP LTD working capital to net assets ratio. SIMCERE PHARMAC. GRP LTD (S2P) has a Working Capital to Net Assets ratio of 43.0% as of December 2025. Working capital of €4.04 Billion (current assets of €7.39 Billion minus current liabilities of €3.35 Billion) is measured against net assets of €9.41 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check SIMCERE PHARMAC. GRP LTD (S2P) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of SIMCERE PHARMAC. GRP LTD (2021–2025)
Working capital to net assets ratio of SIMCERE PHARMAC. GRP LTD from 2021 to 2025. This chart shows how SIMCERE PHARMAC. GRP LTD's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 43.0%, reflecting working capital of €4.04 Billion against net assets of €9.41 Billion EUR. See operational self-sufficiency of SIMCERE PHARMAC. GRP LTD to measure how many days the company can operate on defensive assets alone.
SIMCERE PHARMAC. GRP LTD Working Capital to Net Assets Ratio by Year (2021–2025)
SIMCERE PHARMAC. GRP LTD working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for SIMCERE PHARMAC. GRP LTD from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of SIMCERE PHARMAC. GRP LTD.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 43.0% | €4.04 Billion | €9.41 Billion | €7.39 Billion | €3.35 Billion | ▲ +4.2 pp |
| 2024 | 38.7% | €2.74 Billion | €7.07 Billion | €5.47 Billion | €2.73 Billion | ▼ -2.1 pp |
| 2023 | 40.9% | €2.95 Billion | €7.22 Billion | €5.64 Billion | €2.69 Billion | ▲ +6.0 pp |
| 2022 | 34.9% | €2.49 Billion | €7.15 Billion | €5.46 Billion | €2.97 Billion | ▲ +5.2 pp |
| 2021 | 29.6% | €1.92 Billion | €6.46 Billion | €4.98 Billion | €3.06 Billion | — |